Nohla Therapeutics
PrivateCompany Overview
Nohla Therapeutics operates in Healthcare & Life Sciences and is based in Seattle, Washington. It was founded in 2015.
Nohla Therapeutics is a biotechnology company that develops off-the-shelf, universal donor cellular therapies for patients with hematologic malignancies and other critical diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nohla Therapeutics Comparables
Compare Nohla Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ExCellThera | 82% | |
| Angiocrine Bioscience | 79% | |
| Gamida Cell Ltd. | 78% |
For institutional investors. Book with your work email.
Nohla Therapeutics Funding Rounds
Historical fundraising activity
Nohla Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nohla Therapeutics's valuation, stock price, and market status.
Is Nohla Therapeutics a public or private company?
Nohla Therapeutics is a private company.
What is the current stock price of Nohla Therapeutics?
Nohla Therapeutics is a private company, so its shares have no public market price. Caplight tracks Nohla Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nohla Therapeutics worth (valuation)?
Valuation information for Nohla Therapeutics is not publicly available.
Can I buy Nohla Therapeutics stock?
Nohla Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nohla Therapeutics's last funding round?
Funding round information for Nohla Therapeutics is not publicly available.
Who are the main investors in Nohla Therapeutics?
Investor information for Nohla Therapeutics is not publicly disclosed.
Will Nohla Therapeutics IPO soon?
No public IPO plans have been announced for Nohla Therapeutics.
How can I track Nohla Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Nohla Therapeutics's shares on secondary markets.